Search Results

A 740003 50mg 50mg  | Purity Not Available

Adooq Bioscience

A 740003 is a novel competitive antagonist of P2X7 receptors (IC50 values = 40 nM for human and 18 nM for rat).

More Information Supplier Page

A 740003 25mg 25mg  | Purity Not Available

Adooq Bioscience

A 740003 is a novel competitive antagonist of P2X7 receptors (IC50 values = 40 nM for human and 18 nM for rat).

More Information Supplier Page

A 740003 100mg 100mg  | Purity Not Available

Adooq Bioscience

A 740003 is a novel competitive antagonist of P2X7 receptors (IC50 values = 40 nM for human and 18 nM for rat).

More Information Supplier Page

A 740003 10mg 10mg  | Purity Not Available

Adooq Bioscience

A 740003 is a novel competitive antagonist of P2X7 receptors (IC50 values = 40 nM for human and 18 nM for rat).

More Information Supplier Page

Moxonidine 100mg 100mg  | Purity Not Available

Adooq Bioscience

Moxonidine is a new-generation centrally-acting antihypertensive drug. It may have a role when thiazides, beta-blockers, ACE inhibitors and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistance syndrome, apparently independent of blood pressure reduction.

More Information Supplier Page

Moxonidine 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Moxonidine is a new-generation centrally-acting antihypertensive drug. It may have a role when thiazides, beta-blockers, ACE inhibitors and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistance syndrome, apparently independent of blood pressure reduction.

More Information Supplier Page